Cargando…
Liver resection for hepatocellular carcinoma beyond the BCLC: are multinodular disease, portal hypertension, and portal system invasion real contraindications?
BACKGROUND: Barcelona Clinic Liver Cancer (BCLC) is a recognized guideline to standardize treatment allocation for hepatocellular carcinoma (HCC); however, many centers criticize its restrictive liver resection recommendations and have published good results after more liberal hepatectomy indication...
Autores principales: | Barros, Andrea Zaidan de Almeida, Fonseca, Gilton Marques, Kruger, Jaime Arthur Pirola, Coelho, Fabricio Ferreira, Herman, Paulo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830367/ https://www.ncbi.nlm.nih.gov/pubmed/36636072 http://dx.doi.org/10.21037/jgo-22-833 |
Ejemplares similares
-
HEPATOSPLENIC SCHISTOSOMIASIS-ASSOCIATED CHRONIC PORTAL VEIN THROMBOSIS: RISK FACTOR FOR HEPATOCELLULAR CARCINOMA?
por: Darce, George Felipe Bezerra, et al.
Publicado: (2023) -
LAPAROSCOPIC LIVER RESECTION FOR BENIGN TUMORS: THE CURRENT
POSITION
por: HERMAN, Paulo, et al.
Publicado: (2022) -
LIVER RESECTION IN BRAZIL: A NATIONAL SURVEY
por: FONSECA, Gilton Marques, et al.
Publicado: (2018) -
Total laparoscopic vs. open liver resection: comparative study with
propensity score matching analysis
por: de ASSIS, Bruno Silva, et al.
Publicado: (2020) -
The impact of multivisceral liver resection on short- and long-term outcomes of patients with colorectal liver metastasis: A systematic review and meta-analysis
por: Silveira Júnior, Sérgio, et al.
Publicado: (2022)